The U.S. Food and Drug Administration has approved Lantidra, a cellular therapy medication used for the treatment of type 1 diabetes.
The FDA granted approval of Lantidra to Chicago-based biotech CellTrans Inc.
Lantidra is approved for treating adult diabetic patients who are unable to approach target average blood glucose levels because of repeated episodes of severe low blood sugar leves.
Donislecel, sold under the brand name Lantidra, is the first allogeneic pancreatic islet cellular therapy, consisting of insulin-producing islet beta cells made from the pancreatic cells of a deceased donor.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.